Clinical Trials
🇺🇸 FDA Page 2FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 13–24 of 376 articles
Adial Pharmaceuticals Azora merger and AT177
Biotech coming age: AI, capital, China
Edgewise EDG-7500 Posts Positive Phase 2 CIRRUS-HCM Data in Obstructive HCM
New therapies in celiac disease: 2026 pipeline
Neumora navacaprant fails Phase 3 as EnGene cuts 50% of staff
Lilly buys 4E in non-opioid pain push: what investors should watch
Global hematology trials keep research patient-centered and regionally relevant
Hillhurst Bio doses first subject in Phase 2a HBI-002 Parkinson's trial
FDA approves belzutifan plus pembrolizumab for adjuvant RCC
Planning a successful pivot from lab to clinic: a practical career map
HFMA conference: Affordability was the focus, but fixes remained unclear
FDA Clears First OTC CGM for Children: Dexcom Expands Stelo